Forum starts in

9.2. Intellectual Property in Pharmaceutics. Balance Between Private and Public Interests

Friday, 17 May
13:00 - 14:30

Hall #4, General Staff Building (6-8, Dvortsovaya sq.)

The session will include the discussion of such issues as:

  • Disputes on exclusivity violations in pharmaceutics.
  • Compulsory licensing: today and tomorrow.
  • Inventions quality assessment.
  • Patents invalidation procedures.


Vitaliy Kastalskiy

Managing Partner, Kastalskiy and Partners


Anna Guseva

Partner, Ernst and Young

Anna Kostyra

Managing Partner, Deloitte

Nikolay Lyskov

Head of the Department of Chemistry, Biotechnology and Medicine, Federal Institute of Industrial Property

Vironika Pilyugina

Counsel, Hogan Lovells CIS

Pavel Sadovsky

Counsel, Egorov Puginsky Afanasiev and Partners

First Row Experts

Irina Chernenko

Legal Affairs Director, Johnson & Johnson LLC

Kseniya Nasonova

Head Patent Expert, GEROPHARM

Polina Presnyakova

Legal Affairs Director and Compliance Officer, EAEU, JSC Servier

Dmitriy Zaytsev

Deputy Director General of Intellectual Property, JSC Pharmstandard

* The Programme may be subject to change